We are live on ! Find out more
GX

Greylock XII Portfolio holdings

AUM $51.9M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
-26.72%
1 Year Est. Return
-11.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$80M
AUM Growth
-$62M
Cap. Flow
-$24.3M
Cap. Flow %
-30.41%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CLDR
Cloudera, Inc.
CLDR
+$22.7M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$1.6M

Sector Composition

Rank Sector Weight
1 Real Estate 75.15%
2 Technology 23.63%
3 Healthcare 1.22%
4 Miscellaneous 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDFN
1
DELISTED
Redfin
RDFN
$60.1M 75.15%
4,177,012
– –
CLDR
2
DELISTED
Cloudera, Inc.
CLDR
$18.9M 23.63%
1,709,865
-1,710,000
-50% -$22.7M
KALA icon
3
KALA BIO
KALA
$15.7M
$976K 1.22%
80
– –
RYTM icon
4
Rhythm Pharmaceuticals
RYTM
$7.75B
– –
-54,749
Closed -$1.6M

Similar funds

KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
SCPM
Sagard Capital Partners Management New York $46.7M AUM 23.43% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return

Greylock XII's Q4 2018 Portfolio in Review

As of Q4 2018, Greylock XII held 4 positions worth $80M, down 44% from $142M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Greylock XII withdrew a net $24.3M in Q4 2018, closing 1 position and reducing 1 holding. Its most notable exit was Rhythm Pharmaceuticals, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 75% of assets, up from 55% a quarter earlier, followed by Technology and Healthcare.

  • Greylock XII's biggest Q4 2018 reduction was Cloudera, Inc., cutting an estimated $22.7M.
  • Greylock XII fully exited Rhythm Pharmaceuticals in Q4 2018, selling an estimated $1.6M.
  • Greylock XII's ten largest holdings make up 100% of its $80M portfolio in Q4 2018.
  • Greylock XII opened 0 new positions and closed 1 in Q4 2018.
  • Greylock XII's portfolio value fell 44% quarter-over-quarter to $80M.

Based on Greylock XII's 13F filing for Q4 2018, filed 1 May 2019.